Literature DB >> 30211842

Interleukin 9 Alters Epithelial Barrier and E-cadherin in Eosinophilic Esophagitis.

Ashmi Doshi1,2,3, Rebecca Khamishon1,2,3, Renee Rawson1,2, Loan Duong1,2, Lucas Dohil1,2, Stephen J Myers1,2,3, Braxton Bell1,2, Ranjan Dohil4,2, Robert O Newbury2,5, Kim E Barrett1,4,3, Richard C Kurten6, Seema S Aceves1,2,3.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic TH2-assocated inflammatory condition accompanied by substantial impairments in epithelial barrier function and increased numbers of interleukin 9 (IL-9) expressing inflammatory cells. While IL-9 is known to affect barrier function in the intestine, the functional effects of IL-9 on the esophagus are unclear. Herein we aimed to understand the expression of the IL-9 receptor and effects of IL-9 on the epithelium in EoE.
METHODS: We used esophageal biopsies from pediatric EoE patients with active and inactive disease to analyze the expression of the IL-9 receptor, the adherens junction protein E-cadherin and the tight junction protein claudin-1. We treated primary human esophageal epithelial cells with IL-9 to understand its effects on E-cadherin expression and function.
RESULTS: Active EoE subjects had increased epithelial expression of IL-9 receptor mRNA and protein (P < 0.05) and decreased membrane bound E-cadherin (P < 0.01) and claudin-1 (P < 0.05) expression. IL-9 receptor expression and mislocalized claudin-1 positively correlated and while membrane bound E-cadherin expression negatively correlated with the degree of histologic epithelial remodeling (P < 0.05). IL-9 decreased epithelial resistance in stratified primary human esophageal epithelial cells (P < 0.01) and membrane bound E-cadherin in epithelial cell monolayers (P < 0.01).
CONCLUSIONS: These data suggest that IL-9, its receptor, and its effects on E-cadherin may be important mechanisms for epithelial barrier disruption in EoE.

Entities:  

Year:  2019        PMID: 30211842      PMCID: PMC6344288          DOI: 10.1097/MPG.0000000000002144

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  31 in total

1.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

2.  A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.

Authors:  Evan S Dellon; Hannah P Kim; Sarah L W Sperry; David A Rybnicek; John T Woosley; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2013-11-23       Impact factor: 9.427

3.  TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.

Authors:  Lisa Y Beppu; Arjun A Anilkumar; Robert O Newbury; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2014-05-13       Impact factor: 10.793

4.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

5.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.

Authors:  Iris M Otani; Arjun A Anilkumar; Robert O Newbury; Monica Bhagat; Lisa Y Beppu; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

6.  Epidemiology of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2014-03-19       Impact factor: 3.806

Review 7.  IL-9 in allergic inflammation.

Authors:  Hans-Peter Hauber; Celine Bergeron; Qutayba Hamid
Journal:  Int Arch Allergy Immunol       Date:  2004-05-05       Impact factor: 2.749

8.  Bile salts disrupt human esophageal squamous epithelial barrier function by modulating tight junction proteins.

Authors:  Xin Chen; Tadayuki Oshima; Jing Shan; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-10       Impact factor: 4.052

9.  IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.

Authors:  Jennifer Kearley; Jonas S Erjefalt; Cecilia Andersson; Ebony Benjamin; Carla P Jones; Annette Robichaud; Sophie Pegorier; Yambasu Brewah; Timothy J Burwell; Leif Bjermer; Peter A Kiener; Roland Kolbeck; Clare M Lloyd; Anthony J Coyle; Alison A Humbles
Journal:  Am J Respir Crit Care Med       Date:  2010-10-22       Impact factor: 21.405

Review 10.  Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives.

Authors:  Quan M Nhu; Seema S Aceves
Journal:  Front Med (Lausanne)       Date:  2017-08-07
View more
  8 in total

1.  Local Antigen Deposition in Eosinophilic Esophagitis: Implications for Immune Activation.

Authors:  Seema S Aceves
Journal:  Gastroenterology       Date:  2019-05-28       Impact factor: 22.682

2.  Epithelial Claudin Proteins and Their Role in Gastrointestinal Diseases.

Authors:  David Y Kim; Glenn T Furuta; Nathalie Nguyen; Eisuke Inage; Joanne C Masterson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-05       Impact factor: 2.839

3.  Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function.

Authors:  Mirelle T A Kleuskens; Maria L Haasnoot; Bart M Herpers; Marleen T J van Ampting; Albert J Bredenoord; Johan Garssen; Frank A Redegeld; Betty C A M van Esch
Journal:  Allergy       Date:  2021-09-12       Impact factor: 14.710

4.  Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis.

Authors:  Sathisha Upparahalli Venkateshaiah; Chandra Sekhar Yadavalli; Hemanth Kumar Kandikattu; Sandeep Kumar; Lokanatha Oruganti; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-04-19       Impact factor: 4.871

5.  IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation.

Authors:  Jiaoyue Hu; Ning Gao; Yun Zhang; Xin Chen; Jinmiao Li; Fang Bian; Wei Chi; Zuguo Liu; Cintia S de Paiva; Stephen C Pflugfelder; De-Quan Li
Journal:  Mucosal Immunol       Date:  2020-05-01       Impact factor: 7.313

Review 6.  Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.

Authors:  Alfred D Doyle; Mia Y Masuda; Hirohito Kita; Benjamin L Wright
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

7.  Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.

Authors:  Quan M Nhu; Lance Hsieh; Lucas Dohil; Ranjan Dohil; Robert O Newbury; Richard Kurten; Fouad J Moawad; Seema S Aceves
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

8.  Integrin αEβ7 is involved in the intestinal barrier injury of sepsis.

Authors:  Jia-Kui Sun; Qian Zhang; Xiao Shen; Jing Zhou; Xiang Wang; Su-Ming Zhou; Xin-Wei Mu
Journal:  Aging (Albany NY)       Date:  2022-01-18       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.